These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9088552)

  • 1. Biological assays: their role in the development and quality control of recombinant biological medicinal products.
    Mire-Sluis AR; Gerrard T; Das RG; Padilla A; Thorpe R
    Biologicals; 1996 Dec; 24(4):351-62. PubMed ID: 9088552
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of bioassays in the assessment of recombinant proteins.
    Jeffcoate SL
    Dev Biol Stand; 1994; 83():159-64. PubMed ID: 7883090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control for screening-assays by means of control charts: polio vaccine testing as an example.
    Vogel I
    Dev Biol Stand; 1996; 86():346. PubMed ID: 8785986
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology.
    Thorpe R; Wadhwa M; Mire-Sluis A
    Dev Biol Stand; 1997; 91():79-88. PubMed ID: 9413686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for valid alternative assays for testing of biological therapeutic agents.
    Sesardic D
    Dev Biol Stand; 1996; 86():311-8. PubMed ID: 8785962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality control of biotechnology products.
    Federici MM
    Biologicals; 1994 Jun; 22(2):151-9. PubMed ID: 7917231
    [No Abstract]   [Full Text] [Related]  

  • 7. The target animal safety test--is it still relevant?
    Advisory Group on Alternatives to Animal Testing in Immunobiologicals
    Biologicals; 2002 Dec; 30(4):277-87. PubMed ID: 12474863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensuring quality of in vitro alternative test methods: Current practice.
    Rispin A; Stitzel K; Harbell J; Klausner M
    Regul Toxicol Pharmacol; 2006 Jul; 45(2):97-103. PubMed ID: 16644076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of potency for well characterized biotechnology proteins.
    Finbloom DS
    Dev Biol Stand; 1998; 96():63-4. PubMed ID: 9890518
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia.
    Artiges A
    Dev Biol Stand; 1999; 101():29-35. PubMed ID: 10566772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-characterized biotechnology products: evolving to meet the needs of the 21st century.
    Zoon KC
    Dev Biol Stand; 1998; 96():3-8. PubMed ID: 9890510
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic stability and recombinant product consistency.
    Burstyn D; Copmann T; Dinowitz M; Garnick R; Losikoff A; Lubiniecki A; Wiebe M
    Biologicals; 1993 Jun; 21(2):147-9. PubMed ID: 8297595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic stability and product consistency of rDNA derived biologicals.
    Lambert KJ
    Biologicals; 1993 Jun; 21(2):151. PubMed ID: 8297596
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic stability: an issue of product quality.
    Burns N
    Biologicals; 1993 Jun; 21(2):145-6. PubMed ID: 8297594
    [No Abstract]   [Full Text] [Related]  

  • 15. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic stability and product consistency of rDNA-derived biologicals from mammalian cells.
    Bebbington CR; Lambert K
    Dev Biol Stand; 1994; 83():183-4. PubMed ID: 7883094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of alternative methods by the EDQM and the Biological Standardization Program].
    Buchheit KH
    ALTEX; 2001; 18(1):19-22. PubMed ID: 11248845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensuring the consistency of rDNA-derived biologicals: the contribution of gene sequencing.
    Griffiths E
    Dev Biol Stand; 1994; 83():179-82. PubMed ID: 7883093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of assay validation in specification development.
    Baffi RA
    Dev Biol Stand; 1997; 91():105-13. PubMed ID: 9413687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in animal use in the production and testing of biologicals.
    Festing MF
    Dev Biol Stand; 1999; 101():195-200. PubMed ID: 10566793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.